- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04955236
Partial Scalp Block in Posterior Fossa Surgery
Partial Scalp Block Versus Fentanyl Infusion in Patients Undergoing Posterior Fossa Surgery Under General Anesthesia. A Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pain in patients undergoing posterior fossa surgery is regarded as more intense when compared to pain in patients undergoing supratentorial cranial surgeries. The main cause has been attributed to the substantial muscle dissection and trauma in this area.
Opioids remain as the current gold standard drugs for operative pain relief. However, exposure to large doses leads to multiple side effects of varying significance, such as nausea, vomiting, dizziness, constipation, respiratory depression, hypoventilation and disorders of breathing during sleep. Therefore, strategies other than opioids are recommended without sacrificing proper and effective analgesia.
Considering the previously mentioned facts, supplementing general anesthesia with regional anesthesia has been considered and was found to improve intraoperative hemodynamics, surgical field and postoperative analgesia.
In neurosurgery, scalp blocks and local anesthetic infiltration are being used along with general anesthesia either preoperatively to decrease the hemodynamic response to head pinning and surgical incision or postoperatively before emergence from anesthesia to decrease postoperative pain and result in a better outcome.
The current study aims to compare between partial scalp block(greater,lesser and third occipital nerve blocks) on the one hand versus fentanyl infusion on the other hand as pain controlling measures reflected on intraoperative hemodynamics in patients undergoing posterior fossa surgery.
After approval of ethics research committee and obtaining informed written consents from the patient's first degree relatives, 40 patients will be randomly divided by computer designed lists and then concealed in closed serially numbered, opaque envelopes into 2 equal groups to receive either partial scalp block(greater,lesser and third occipital nerve blocks) or fentanyl infusion after induction of general anesthesia by a conventional method and assuming the prone position.
For group N (partial nerve block group): The scalp blocks will be performed bilaterally after assuming the prone position by an anesthesiologist who will not be a part of the study team nor will be involved in the proceeding data analysis or other parts of the study. The Greater occipital will be blocked by injecting 3ml of local anaesthetic at a point half way between the mastoid process the external occipital protuberance along the superior nuchal line, medial to the occipital artery. The Lesser occipital nerve will be blocked by injecting 3ml of local anaesthetic infiltration along the superior nuchal line, 2.5 cm lateral to the greater occipital nerve block. The greater occipital nerve block will also cover the third occipital nerve due to the close location of the two nerves (8).
To anesthetize the dura Lidocaine soaked gauzes will be used and applied for 10 minutes before dural incision.
A placebo infusion (normal saline) was administered at the same rate as fentanyl infusion (1 µg/kg/hr.).
For group F ( Fentanyl group):1µg/kg/hr. of intravenous fentanyl infusion will be administered. A syringe filled with 20 ml of normal saline will be prepared and 3 ml of normal saline will be injected at the same points of the partial scalp block previously mentioned. Both the syringe containing bupivacaine and adrenaline and the placebo syringe will be prepared by a blinded clinical pharmacist, who will not be a part of the study team nor will be involved in the proceeding data analysis or other parts of the study.
The primary outcome will be the systolic blood pressure at time of skin incision. the sample size was calculated using the medcalc software. Based on the study "Bupivacaine scalp nerve block: Hemodynamic response during craniotomy, intraoperative and post-operative analgesia" published in Asian biomedicine (2010).
The total sample size required was 36 participants to be randomly allocated between two groups to achieve a confidence level of 95%, power of study 80% with confidence interval of 1. The sample size was increased to 40 (20 per group) to guard against dropouts.
SPSS software will be used for data analysis. Categorical data will be expressed as frequencies and percentages and will be analyzed using chi-square test. Continuous data will be tested for normality by means of shapiro-wilk test and will be analyzed using unpaired t test, Mann Whitney test, and analysis of variance test (ANOVA) as appropriate. The numerical data will be presented as mean and standard deviation or median and interquartile range as appropriate. A P value less than 0.05 will be considered significant.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11687
- Kasr El Aini Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Physical status ASA I and ASA ll.
- Males and females between the ages of 21 and 55.
- Patients undergoing posterior fossa Surgeries.
- Patients with GCS ≥14
- Patients undergoing operation in prone position
Exclusion Criteria:
- Patient refusal.
- Patients with a history of allergy to opioids or local anesthetics
- GCS (Glasgow coma score) ≤13 upon emergence from anesthesia.
- Patients who will need post-operative ventilation
- Patients who had previous craniotomies
- Patients with contraindication to regional anaesthesia e.g.: local sepsis,
- Patients with pre-existing peripheral neuropathies and coagulopathy.
- Patients who will develop intraoperative surgical complications
- Operations lasting more than 5 hours.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Partial scalp block
Bilateral block of the greater lesser and third occipital nerves using bupivacaine 0.25% with epinephrine 1:200,000
|
Partial scalp blocks will be performed bilaterally after assuming the prone position.The Greater occipital will be blocked by injecting 3ml of local anaesthetic at a point half way between the mastoid process the external occipital protuberance along the superior nuchal line, medial to the occipital artery. The Lesser occipital nerve will be blocked by injecting 3ml of local anaesthetic infiltration along the superior nuchal line, 2.5 cm lateral to the greater occipital nerve block. The greater occipital nerve block also will cover the third occipital nerve due to the close location of the two nerves. A placebo infusion (normal saline) will be administered at the same rate as fentanyl infusion in the active comparator arm(1 µg/kg/hr.).
Other Names:
|
|
Active Comparator: Fentanyl group
Fentanyl infusion will be administered till time of dural closure
|
1µg/kg/hr. of intravenous fentanyl infusion will be administered.
A syringe filled with 20 ml of normal saline will be prepared and 3 ml of normal saline will be injected at the same points of the partial scalp block previously described
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic blood pressure at time of skin incision
Time Frame: During surgery, 1 min after skin incision
|
Recording of the systolic blood pressure in mmhg at the time of skin incision
|
During surgery, 1 min after skin incision
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of intraoperative fentanyl boluses
Time Frame: During surgery
|
Total fentanyl boluses in micrograms which will be administered intraoperatively when heart rate and/or systolic arterial pressure values will exceed the baseline values by 25%
|
During surgery
|
|
RASS score
Time Frame: One hour after the surgery
|
Richmond agitation sedation score is a score used to describe the patients' level of alertness or agitation.
It ranges from from -5 unarousable to +4 combative with 0 meaning alert and calm
|
One hour after the surgery
|
|
Time for first rescue Analgesia
Time Frame: after the surgery
|
First time when the patient starts to complain of pain after surgery and an analgesic is given
|
after the surgery
|
|
Number of heart beats per minute (Heart rate)
Time Frame: baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
Number of heart beats per minute
|
baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
|
Systolic blood pressure
Time Frame: baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
systolic blood pressure in mmhg
|
baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
|
Mean arterial blood pressure
Time Frame: baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
Mean arterial blood pressure in mmhg
|
baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
|
Diastolic blood pressure
Time Frame: baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
Diastolic blood pressure in mmhg
|
baseline, 5 min after the induction of anesthesia, 5 min after the scalp block, 1 min after skin incision, 1 min after dural incision, at time of dural closure, 1 min after skin closure, at time of extubation.
|
|
Intraoperative phentolamine consumption
Time Frame: throughout the operation
|
the total amount of phentolamine in mg consumed intraoperatively
|
throughout the operation
|
|
Intraoperative ephedrine consumption
Time Frame: throughout the operation
|
the total amount of ephedrine in mg consumed intraoperatively
|
throughout the operation
|
|
Time to extubation
Time Frame: At the end of the operation, the time from the discontinuation of inhalation agents till extubation
|
It is the time between closure of inhalational anesthetic and extubation
|
At the end of the operation, the time from the discontinuation of inhalation agents till extubation
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec;83(6):1256-61. doi: 10.1097/00000539-199612000-00022.
- Vadivelu N, Kai AM, Tran D, Kodumudi G, Legler A, Ayrian E. Options for perioperative pain management in neurosurgery. J Pain Res. 2016 Feb 10;9:37-47. doi: 10.2147/JPR.S85782. eCollection 2016.
- Jian M, Li X, Wang A, Zhang L, Han R, Gelb AW. Flurbiprofen and hypertension but not hydroxyethyl starch are associated with post-craniotomy intracranial haematoma requiring surgery. Br J Anaesth. 2014 Nov;113(5):832-9. doi: 10.1093/bja/aeu185. Epub 2014 Jun 25.
- Osborn I, Sebeo J. "Scalp block" during craniotomy: a classic technique revisited. J Neurosurg Anesthesiol. 2010 Jul;22(3):187-94. doi: 10.1097/ANA.0b013e3181d48846.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms
- Neoplasms by Site
- Brain Neoplasms
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Infratentorial Neoplasms
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Fentanyl
Other Study ID Numbers
- MS-317-2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posterior Fossa Tumor
-
University of California, San FranciscoPediatric Neuro-Oncology Consortium; The Lilabean Foundation, Inc.RecruitingPosterior Fossa Ependymal TumorUnited States
-
Assiut UniversityNot yet recruitingPediatric Tumor | Midline Posterior Fossa Tumors
-
Hospices Civils de LyonCompletedPosterior Brain Fossa Tumors in ChildrenFrance
-
University of Health Sciences LahoreNot yet recruitingPosterior Fossa Lesion
-
Baxter Healthcare CorporationCompletedDura Defects | Pathological Processes in the Posterior FossaUnited States, Canada
-
Istanbul UniversityCompleted
-
Children's National Research InstituteWithdrawnArnold-Chiari Malformation | Posterior Fossa TumorsUnited States
-
IRCCS Eugenio MedeaRecruiting
-
Medical University InnsbruckRecruitingIntracranial Pressure Increase | Posterior Fossa Lesion | Posterior Fossa HemorrhageAustria
-
Great Ormond Street Hospital for Children NHS Foundation...CompletedCerebellar Mutism | Posterior Fossa SyndromeUnited Kingdom
Clinical Trials on Partial scalp block
-
Cairo UniversityNot yet recruiting
-
Sakarya UniversityNot yet recruitingRegional Anesthesia | Craniotomy Surgery | Scalp Block | QoR-40Turkey
-
University of Roma La SapienzaUnknownSupratentorial Neoplasms
-
Sohag UniversityRecruiting
-
Beijing Tiantan HospitalActive, not recruiting
-
Hamad Medical CorporationRecruitingHeadache Disorders | Aneurysmal Subarachnoid Hemorrhage (aSAH)Qatar
-
Bangladesh Medical UniversityNot yet recruiting
-
University of LiegeUnknown
-
Beijing Tiantan HospitalNot yet recruitingPostoperative Pain | Analgesia | Supratentorial Brain Tumor
-
Chiang Mai UniversityUnknown